Login / Signup

Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Meta-analysis and trial sequential analysis of randomized controlled trials.

Shahab HajibandehShahab HajibandehChristina IntratorKarim HassanMantej SehmbhiJigar ShahEshan MazumdarAmbareen KausarThomas Satyadas
Published in: Annals of hepato-biliary-pancreatic surgery (2022)
Neoadjuvant CRT might be beneficial for patients with BRPC, but not for patients with RPC. Nevertheless, the best available evidence does not include contemporary chemotherapy regimens. Patients with RPC and those with BRPC should not be combined in the same cohort in future studies.
Keyphrases